Search results

New research suggests that two non-psychoactive cannabis compounds could help treat fatty liver disease, the most common form of chronic liver disorder. Researchers at the Hebrew University of Jerusalem have found that Cannabidiol (CBD) and Cannabigerol (CBG), can significantly reduce liver...

In a fascinating deep dive into human physiology, Dr. Rowan Thompson, resident doctor and Vice Chair of the Medical Cannabis Clinicians Society (MCCS), explores the Endocannabinoid System (ECS)—a complex biological network that remains largely untaught in medical schools despite its pivotal role...

A new UK-wide service supporting medical cannabis patients who face discrimination has launched to fill gaps left by the absence of systematic government support. Patient Protect was founded by patient advocate Alex Fraser and cannabis lawyer Robert Jappie, who have handled cases on a pro-bono...

Labour MP and long-time medical cannabis advocate, Tonia Antoniazzi, has called on the government to fund a new observational trial to support children with drug-resistant epilepsy, who are still unable to access medical cannabis on the NHS. Antoniazzi is spearheading a new campaign launched in...

As cannabis research continues to progress, increasing attention is being given to two promising compounds, cannabigerol (CBG) and its precursor, cannabigerolic acid (CBG-A). Often overshadowed by the more widely recognised cannabinoids THC and CBD, these non-psychoactive compounds are now being...

In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really means...

Polish pharmacies dispensed nearly 5,450 kilograms of dried cannabis flower in 2025, a 12% increase from the prior year, according to new data obtained by Prohibition Partners. By October, monthly volumes had surpassed the pre-ban peak for the first time, reaching a new all-time high in...

A UK medical cannabis patient has won a Crown Court appeal after being wrongly convicted of driving with THC above the legal limit. At Winchester Crown Court on 10 February 2026, Sal Aziz, a legally prescribed medical cannabis patient, was fully acquitted of the charges after the prosecution...

Bristol Medical School has formally approved what is believed to be one of the first student-selected medical cannabis teaching placements offered by a UK university. The move marks a significant step forward for undergraduate education in an area of practice that remains widely under-taught...

Early findings examining the impact of the partial legalisation of cannabis in Germany suggest no short-term spike in consumption or related driving offences, alongside a sharp drop in prosecutions. Researchers at the University Medical Center Hamburg-Eppendorf (UKE) in Germany have...

The first administrative appeal hearing on whether Female Orgasmic Disorder (FOD) should be recognised as a qualifying condition for medical cannabis is taking place in the US state of Oregon this week. From 3 to 5 February, state officials will hear testimony from clinicians, researchers, and...

A new study suggests a combination approach may provide the benefits of THC treatment in Alzheimer’s with fewer negative side effects. Researchers from The University of Texas at San Antonio paired a low-dose THC extract with the selective anti-inflammatory drug celecoxib. Their findings...

A recent peer-reviewed paper has identified a previously unrecognised form of reporting bias that may be skewing how medical cannabis evidence is presented. The paper, published in Research Integrity and Peer Review, introduces the concept of reverse spin bias – a pattern in which authors of...

In the first double-blind, placebo-controlled trial, vaporised cannabis was found to be more effective for treating acute migraine symptoms than a placebo. While preclinical and retrospective studies have suggested cannabinoids may be effective in migraine treatment, according to the...

Researchers in the UK have proposed new thresholds for monitoring cannabis use – modelled on alcohol units – which they say could help people avoid potentially harmful consumption. The threshold recommendations, proposed in a paper published in the journal Addiction, are based on a system for...

Patients and healthcare professionals have responded to recent media coverage, which they say misrepresented those receiving treatment with cannabis-based medicines in the UK. On 6 January 2026, the National Police Chiefs’ Council (NPCC) approved the first official guidance on medical cannabis...

A new research consultancy is giving patients a direct voice in how the UK’s medical cannabis market is shaped, as global producers look to better understand the needs of the community. Launching this month, Patient Panel is a new medical cannabis market research consultancy that aims to put...

Last week, the first official guidance on medical cannabis for police officers in England and Wales was made public. Its publication marks a significant step forward for both the patient community and law enforcement, finally providing an initial standardised set of principles for both to...

Over seven years after medical cannabis was legalised in the UK, the National Police Chiefs’ Council has approved the first official guidance for medical cannabis. The guidance, titled ‘Medicinal Cannabis and the Police – Guidance for Officers and Staff’, crucially calls for officers in...

In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really means...